J B Chemicals & Pharmaceuticals Ltd. - Research Center
506943 JBCHEPHARM Group (A) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | Mar ' 18 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 15.46 | 15.46 | 15.46 | 16.05 | 16.71 |
| Share application money | 62.65 | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 2,025.56 | 1,791.00 | 1,429.83 | 1,468.52 | 1,436.67 |
| Loan funds | |||||
| Secured loans | 26.32 | 26.43 | 32.04 | 25.80 | 25.88 |
| Unsecured loans | - | - | - | - | 2.59 |
| Total | 2,129.98 | 1,832.89 | 1,477.33 | 1,510.36 | 1,481.86 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 1,773.44 | 1,097.48 | 1,094.50 | 1,001.48 | 970.10 |
| Less : revaluation reserve | - | - | - | - | - |
| Less : accumulated depreciation | 569.77 | 532.88 | 511.29 | 449.37 | 400.20 |
| Net block | 1,203.67 | 564.60 | 583.21 | 552.11 | 569.91 |
| Capital work-in-progress | 18.68 | 25.57 | 16.17 | 15.09 | 17.40 |
| Investments | 145.69 | 810.85 | 536.23 | 589.49 | 566.69 |
| Net current assets | |||||
| Current assets, loans & advances | 1,170.04 | 799.41 | 675.41 | 635.42 | 612.66 |
| Less : current liabilities & provisions | 408.08 | 367.54 | 333.69 | 281.76 | 284.79 |
| Total net current assets | 761.95 | 431.87 | 341.72 | 353.67 | 327.86 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 2,129.98 | 1,832.89 | 1,477.33 | 1,510.36 | 1,481.86 |
| Notes: | |||||
| Book value of unquoted investments | 145.69 | 145.88 | 145.85 | 145.00 | 143.07 |
| Market value of quoted investments | - | 664.97 | 390.38 | 444.49 | 423.62 |
| Contingent liabilities | 68.13 | 117.00 | 121.66 | 86.45 | 173.76 |
| Number of equity sharesoutstanding (Lacs) | 772.82 | 772.82 | 772.82 | 802.37 | 835.70 |
© 2023 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis